Zhang Yi, Xu Xiaoman
Department of Gerontology and Geriatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Front Pharmacol. 2022 Apr 13;13:879459. doi: 10.3389/fphar.2022.879459. eCollection 2022.
Depression is one of the most common non-motor symptoms in patients with Parkinson's disease (PD). Depression in PD (DPD) increases the disability rate and reduces the quality of life of PD patients and increases the caregiver burden. Although previous studies have explained the relationship between depression and PD through a variety of pathological mechanisms, whether depression is a precursor or an independent risk factor for PD remains unclear. Additionally, increasing evidence shows that conventional anti-PD drug therapy is not ideal for DPD. Chinese Herbal Medicine (CHM) prescriptions exhibit the characteristics of multi-target, multi-pathway, and multi-level treatment of DPD and may simultaneously improve the motor symptoms of PD patients through multiple mechanisms. However, the specific pharmacological mechanisms of these CHM prescriptions remain unelucidated. Here, we investigated the mechanisms of action of the active ingredients of single herbs predominantly used in CHM prescriptions for depression as well as the therapeutic effect of CHM prescriptions on DPD. This review may facilitate the design of new selective and effective treatment strategies for DPD.
抑郁症是帕金森病(PD)患者最常见的非运动症状之一。帕金森病伴发的抑郁症(DPD)会增加残疾率,降低PD患者的生活质量,并加重照料者的负担。尽管先前的研究已通过多种病理机制解释了抑郁症与PD之间的关系,但抑郁症是PD的先兆还是独立危险因素仍不清楚。此外,越来越多的证据表明,传统的抗PD药物治疗对DPD并不理想。中药方剂在治疗DPD方面具有多靶点、多途径、多层次的特点,并且可能通过多种机制同时改善PD患者的运动症状。然而,这些中药方剂的具体药理机制仍未阐明。在此,我们研究了主要用于治疗抑郁症的中药方剂中单一草药活性成分的作用机制以及中药方剂对DPD的治疗效果。本综述可能有助于设计新的针对DPD的选择性有效治疗策略。